$COLL COLLEGIUM PHARMACEUTICAL, INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in COLLEGIUM PHARMACEUTICAL, INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in COLLEGIUM PHARMACEUTICAL, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in COLLEGIUM PHARMACEUTICAL, INC for free.

CIK Number: 0001267565
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: COLL
Company Address: 100 TECHNOLOGY CENTER DRIVE STOUGHTON 02072
Phone number: 781-713-3699
Former name: COLLEGIUM PHARMACEUTICAL INC, date of change: 2003-10-20

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The firm engages in the development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta IR is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Market Capitalization: $351.67M
Prev close: $15.36
Average Daily Volume: 226,161
Days Low: $14.72
Year Low: $8.24
Year High: $21.45

COLLEGIUM PHARMACEUTICAL, INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 24 2021COLLCOLLEGIUM PHARMACE ...Freund John GordonDirectorGrantA0.009,941020,94811 K to 20.9 K (+90.32 %)
May 12 2021COLLCOLLEGIUM PHARMACE ...Kuhlmann Shirley R.EVP and General Cou ...SellS22.777,000159,39089,99097 K to 90 K (-7.22 %)
Apr 05 2021COLLCOLLEGIUM PHARMACE ...Malamut RichardEVP and Chief Medic ...Payment of ExerciseF23.383,11972,92293,55896.7 K to 93.6 K (-3.23 %)
Apr 05 2021COLLCOLLEGIUM PHARMACE ...Fleming Alison BEVP & Chief Technic ...Payment of ExerciseF23.387,900184,702145,080153 K to 145.1 K (-5.16 %)
Apr 05 2021COLLCOLLEGIUM PHARMACE ...Fleming Alison BEVP & Chief Technic ...Payment of ExerciseF23.381,75741,079152,980154.7 K to 153 K (-1.14 %)
Mar 18 2021COLLCOLLEGIUM PHARMACE ...Kuhlmann Shirley R.EVP and General Cou ...Payment of ExerciseF24.6973418,12296,99097.7 K to 97 K (-0.75 %)
Mar 17 2021COLLCOLLEGIUM PHARMACE ...Heffernan Michael ThomasDirectorSellS25.883,03178,4424,0477.1 K to 4 K (-42.82 %)
Mar 17 2021COLLCOLLEGIUM PHARMACE ...Heffernan Michael ThomasDirectorSellS25.2647,0441,188,3317,07854.1 K to 7.1 K (-86.92 %)
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Ciaffoni JosephPresident and CEOOption ExerciseM8.2248,616399,62416,205
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Ciaffoni JosephPresident and CEOSellS23.309,809228,550278,307288.1 K to 278.3 K (-3.40 %)
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Ciaffoni JosephPresident and CEOSellS22.5654,9591,239,875288,116343.1 K to 288.1 K (-16.02 %)
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Ciaffoni JosephPresident and CEOBuyM8.2248,616399,624343,075294.5 K to 343.1 K (+16.51 %)
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Fleming Alison BChief Technical Off ...Option ExerciseM3.311,4494,7960
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Fleming Alison BChief Technical Off ...Option ExerciseM0.901,8111,6300
Mar 03 2021COLLCOLLEGIUM PHARMACE ...Fleming Alison BChief Technical Off ...Option ExerciseM0.9064580

View all COLLEGIUM PHARMACEUTICAL, INC insider transactions.